A

AprilBio Co Ltd
KOSDAQ:397030

Watchlist Manager
AprilBio Co Ltd
KOSDAQ:397030
Watchlist
Price: 15 390 KRW 2.19% Market Closed
Market Cap: 345.4B KRW
Have any thoughts about
AprilBio Co Ltd?
Write Note

AprilBio Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AprilBio Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
AprilBio Co Ltd
KOSDAQ:397030
Revenue
â‚©0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Revenue
â‚©2.9T
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
23%
SK Bioscience Co Ltd
KRX:302440
Revenue
â‚©369.5B
CAGR 3-Years
18%
CAGR 5-Years
30%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Revenue
â‚©363.8B
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Revenue
â‚©317B
CAGR 3-Years
30%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Revenue
â‚©74.4B
CAGR 3-Years
36%
CAGR 5-Years
33%
CAGR 10-Years
N/A
No Stocks Found

AprilBio Co Ltd
Glance View

Market Cap
337.3B KRW
Industry
Biotechnology

AprilBio Co Ltd is a Korea-based company primarily engaged in the biological drug development business. The Company is primarily engaged in the bio-innovative new drug research and development (R&D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals.

Intrinsic Value
16 570.57 KRW
Undervaluation 7%
Intrinsic Value
Price
A

See Also

What is AprilBio Co Ltd's Revenue?
Revenue
0 KRW

Based on the financial report for Dec 31, 2023, AprilBio Co Ltd's Revenue amounts to 0 KRW.

Back to Top